Skip to main content

Taysha Gene Therapies, Inc.

TSHA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001806310

In the last 90 days, Taysha Gene Therapies, Inc. insiders filed 0 open-market purchases and 1 sale; 208 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.

13F holders, Q3 2025

Institutional positions in Taysha Gene Therapies, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
155
+8 vs. Q2 2025
Shares held
264.6M
+6.95M (+2.7%) vs. Q2 2025
Total value
$865.6M
+$270.3M (+45.4%) vs. Q2 2025
New holders
28
61 more added
Sold out
20
34 more reduced

3 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TSHA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2025: 155 institutions
Q1 2021: 46 institutionsQ2 2021: 49 institutionsQ3 2021: 48 institutionsQ4 2021: 65 institutionsQ1 2022: 71 institutionsQ2 2022: 59 institutionsQ3 2022: 54 institutionsQ4 2022: 52 institutionsQ1 2023: 44 institutionsQ2 2023: 39 institutionsQ3 2023: 63 institutionsQ4 2023: 87 institutionsQ1 2024: 109 institutionsQ2 2024: 107 institutionsQ3 2024: 119 institutionsQ4 2024: 131 institutionsQ1 2025: 127 institutionsQ2 2025: 150 institutionsQ3 2025: 155 institutionsQ4 2025: 195 institutionsQ1 2026: 191 institutionsQ2 2026: 208 institutions
Value heldQ3 2025: $865.6M
Q1 2021: $358.5MQ2 2021: $388.6MQ3 2021: $361.9MQ4 2021: $215.6MQ1 2022: $110.9MQ2 2022: $54.7MQ3 2022: $27.0MQ4 2022: $43.8MQ1 2023: $13.3MQ2 2023: $9.05MQ3 2023: $410.6MQ4 2023: $230.3MQ1 2024: $402.2MQ2 2024: $354.3MQ3 2024: $315.5MQ4 2024: $289.8MQ1 2025: $232.0MQ2 2025: $595.4MQ3 2025: $865.6MQ4 2025: $1.48BQ1 2026: $1.18BQ2 2026: $2.03B
Institutions holding TSHA and their total value by quarter
QuarterHoldersValue
Q2 2026208$2.03B
Q1 2026191$1.18B
Q4 2025195$1.48B
Q3 2025155$865.6M
Q2 2025150$595.4M
Q1 2025127$232.0M
Q4 2024131$289.8M
Q3 2024119$315.5M
Q2 2024107$354.3M
Q1 2024109$402.2M
Q4 202387$230.3M
Q3 202363$410.6M
Q2 202339$9.05M
Q1 202344$13.3M
Q4 202252$43.8M
Q3 202254$27.0M
Q2 202259$54.7M
Q1 202271$110.9M
Q4 202165$215.6M
Q3 202148$361.9M
Q2 202149$388.6M
Q1 202146$358.5M

Institutions, Q3 2025

Shares, value and share of portfolio for each institution holding Taysha Gene Therapies, Inc.; share changes are against Q2 2025.

Institutions holding TSHA in Q3 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Dimensional Fund Advisors LP345,163$1.13M0.00%+345,163New
Citadel Advisors LLC367,309$1.20M0.00%−161,684−30.6%Reduced
Sphera Funds Management Ltd.408,146$1.33M0.32%−11,854−2.8%Reduced
Boothbay Fund Management, LLC415,607$1.36M0.04%+415,607New
Acuta Capital Partners, LLC454,827$1.49M1.54%−30,842−6.4%Reduced
Marshall Wace, LLP476,865$1.56M0.00%+397,367+499.8%Added
Gsa Capital Partners LLP477,749$1.56M0.13%+433,059+969.0%Added
Woodline Partners LP500,000$1.64M0.01%−500,254−50.0%Reduced
Nuveen, LLC507,210$1.66M0.00%+42,066+9.0%Added
Jane Street Group, LLC556,785$1.82M0.00%+419,791+306.4%Added
Wellington Management Group LLP568,006$1.86M0.00%−67,962−10.7%Reduced
Rice Hall James & Associates, LLC578,118$1.89M0.10%+578,118New
Royal Bank of Canada583,375$1.91M0.00%+88,064+17.8%Added
Anson Funds Management LP603,500$1.97M0.22%−200,000−24.9%Reduced
Bank of New York Mellon Corp624,839$2.04M0.00%+166,180+36.2%Added
UBS Group AG639,356$2.09M0.00%+378,117+144.7%Added
Alphabet Inc.640,882$2.10M0.09%00.0%Unchanged
Sands Capital Ventures, LLC724,873$2.37M0.52%00.0%Unchanged
Quantum Private Wealth, LLC822,076$2.69M0.79%+6,100+0.7%Added
StemPoint Capital LP839,669$2.75M0.55%−364,272−30.3%Reduced
Tang Capital Management LLC900,000$2.94M0.11%00.0%Unchanged
Granahan Investment Management Inc1,116,629$3.65M0.15%+158,136+16.5%Added
Palo Alto Investors LP1,246,033$4.07M0.75%00.0%Unchanged
Bank of America Corp1,307,287$4.27M0.00%+576,559+78.9%Added
Great Point Partners LLC1,500,000$4.91M2.05%00.0%Unchanged
Northern Trust Corp1,717,178$5.62M0.00%+388,437+29.2%Added
B Group, Inc.1,800,556$5.89M5.63%00.0%Unchanged
Charles Schwab Investment Management Inc1,846,510$6.04M0.00%+1,354,801+275.5%Added
Ally Bridge Group (NY) LLC1,898,112$6.21M5.20%+1,898,112New
Toronto Dominion Bank1,923,962$6.29M0.01%−2,804,844−59.3%Reduced
Jefferies Financial Group Inc.2,156,642$7.05M0.06%−8,157,091−79.1%Reduced
D. E. Shaw & Co., Inc.2,706,434$8.85M0.01%+2,304,925+574.1%Added
ADAR1 Capital Management, LLC2,835,680$9.27M0.92%−174,190−5.8%Reduced
Affinity Asset Advisors, LLC3,000,000$9.81M0.91%+2,800,000+1,400.0%Added
Adage Capital Partners GP, L.L.C.3,328,000$10.9M0.02%−1,511,000−31.2%Reduced
Tybourne Capital Management (HK) Ltd3,700,000$12.1M39.11%−395,000−9.6%Reduced
Baker Bros. Advisors LP4,004,756$13.1M0.09%00.0%Unchanged
Millennium Management LLC4,026,122$13.2M0.01%+1,090,394+37.1%Added
Barclays PLC5,148,112$16.8M0.01%+4,697,611+1,042.8%Added
Geode Capital Management, LLC5,174,516$16.9M0.00%+1,380,944+36.4%Added
Polar Capital Holdings Plc5,293,879$17.3M0.08%+293,879+5.9%Added
Deerfield Management Company, L.P. (Series C)5,386,000$17.6M0.27%00.0%Unchanged
Vestal Point Capital, LP5,500,000$18.0M0.82%+2,500,000+83.3%Added
State Street Corp7,236,465$23.7M0.00%+2,098,155+40.8%Added
Point72 Asset Management, L.P.7,331,470$24.0M0.05%+13,856+0.2%Added
Octagon Capital Advisors LP9,067,500$29.7M4.63%−3,525,000−28.0%Reduced
Siren, L.L.C.11,014,737$36.0M1.41%00.0%Unchanged
Vanguard Group Inc12,849,613$42.0M0.00%+1,955,486+17.9%Added
Goldman Sachs Group Inc13,383,708$43.8M0.01%+796,008+6.3%Added
FMR LLC14,593,412$47.7M0.00%−1,034,410−6.6%Reduced
BlackRock, Inc.16,364,861$53.5M0.00%+3,061,086+23.0%Added
Morgan Stanley19,307,603$63.1M0.00%+2,442,521+14.5%Added
Avoro Capital Advisors LLC21,700,000$71.0M0.92%00.0%Unchanged
Ra Capital Management, L.P.23,555,648$77.0M0.95%00.0%Unchanged
RTW Investments, LP24,354,291$79.6M0.98%−667,293−2.7%Reduced
Suvretta Capital Management, LLC0$00.00%−3,217,449−100.0%Sold out
MPM Oncology Impact Management LP0$00.00%−2,953,562−100.0%Sold out
XTX Topco Ltd0$00.00%−320,737−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−148,357−100.0%Sold out
Los Angeles Capital Management LLC0$00.00%−117,740−100.0%Sold out
Omers Administration Corp0$00.00%−72,900−100.0%Sold out
EntryPoint Capital, LLC0$00.00%−69,109−100.0%Sold out
Renaissance Technologies LLC0$00.00%−54,900−100.0%Sold out
Point72 Asia (Singapore) Pte. Ltd.0$00.00%−25,252−100.0%Sold out
State Board of Administration of Florida Retirement System0$00.00%−22,700−100.0%Sold out
May Hill Capital, LLC0$00.00%−16,051−100.0%Sold out
Howard Capital Management Inc.0$00.00%−14,165−100.0%Sold out
Marex Group plc0$00.00%−12,500−100.0%Sold out
Ieq Capital, LLC0$00.00%−10,063−100.0%Sold out
Atticus Wealth Management, LLC0$00.00%−7,425−100.0%Sold out
Point72 (DIFC) Ltd0$00.00%−4,441−100.0%Sold out
Raymond James Financial Inc0$00.00%−3,605−100.0%Sold out
Headlands Technologies LLC0$00.00%−3,037−100.0%Sold out
Rothschild Investment LLC0$00.00%−105−100.0%Sold out
National Bank of Canada0$00.00%−48−100.0%Sold out
CIBC World Markets Corp––––Not filed
E Fund Management Co., Ltd.––––Not filed
Bordeaux Wealth Advisors LLC––––Not filed